BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 9917431)

  • 1. Control of severe hyperbilirubinemia in full-term newborns with the inhibitor of bilirubin production Sn-mesoporphyrin.
    Martinez JC; Garcia HO; Otheguy LE; Drummond GS; Kappas A
    Pediatrics; 1999 Jan; 103(1):1-5. PubMed ID: 9917431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sn-Mesoporphyrin interdiction of severe hyperbilirubinemia in Jehovah's Witness newborns as an alternative to exchange transfusion.
    Kappas A; Drummond GS; Munson DP; Marshall JR
    Pediatrics; 2001 Dec; 108(6):1374-7. PubMed ID: 11731664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient newborns using an inhibitor of bilirubin production, Sn-mesoporphyrin.
    Valaes T; Drummond GS; Kappas A
    Pediatrics; 1998 May; 101(5):E1. PubMed ID: 9565434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct comparison of Sn-mesoporphyrin, an inhibitor of bilirubin production, and phototherapy in controlling hyperbilirubinemia in term and near-term newborns.
    Kappas A; Drummond GS; Henschke C; Valaes T
    Pediatrics; 1995 Apr; 95(4):468-74. PubMed ID: 7700742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single dose of Sn-mesoporphyrin prevents development of severe hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient newborns.
    Kappas A; Drummond GS; Valaes T
    Pediatrics; 2001 Jul; 108(1):25-30. PubMed ID: 11433050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of jaundice in preterm newborns by an inhibitor of bilirubin production: studies with tin-mesoporphyrin.
    Valaes T; Petmezaki S; Henschke C; Drummond GS; Kappas A
    Pediatrics; 1994 Jan; 93(1):1-11. PubMed ID: 8265301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sn-mesoporphyrin suppression of hyperbilirubinemia in EHBR/Eis rats, an animal model of Dubin-Johnson syndrome.
    Drummond GS; Kappas A
    Pharmacology; 1998 Mar; 56(3):158-64. PubMed ID: 9532616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical trial of tin mesoporphyrin to prevent neonatal hyperbilirubinemia.
    Bhutani VK; Poland R; Meloy LD; Hegyi T; Fanaroff AA; Maisels MJ
    J Perinatol; 2016 Jul; 36(7):533-9. PubMed ID: 26938918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tin-mesoporphyrin in the treatment of severe hyperbilirubinemia in a very-low-birth-weight infant.
    Reddy P; Najundaswamy S; Mehta R; Petrova A; Hegyi T
    J Perinatol; 2003 Sep; 23(6):507-8. PubMed ID: 13679941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tin-mesoporphyrin in the treatment of refractory hyperbilirubinemia due to Rh incompatibility.
    Maisels MJ; Yang H
    J Perinatol; 2012 Nov; 32(11):899-900. PubMed ID: 23128060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Predictive value of umbilical cord blood bilirubin level for subsequent neonatal jaundice].
    Sun G; Wang YL; Liang JF; Du LZ
    Zhonghua Er Ke Za Zhi; 2007 Nov; 45(11):848-52. PubMed ID: 18282419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of feeding type on the efficacy of phototherapy.
    Gulcan H; Tiker F; Kilicdag H
    Indian Pediatr; 2007 Jan; 44(1):32-6. PubMed ID: 17277429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metalloporphyrins for treatment of unconjugated hyperbilirubinemia in neonates.
    Suresh GK; Martin CL; Soll RF
    Cochrane Database Syst Rev; 2003; (2):CD004207. PubMed ID: 12804504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tin-metalloporphyrins: an answer to neonatal jaundice?
    Steffensrud S
    Neonatal Netw; 1998 Aug; 17(5):11-7; quiz 18-9. PubMed ID: 9791442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tin-mesoporphyrin, a potent heme oxygenase inhibitor, for treatment of intracerebral hemorrhage: in vivo and in vitro studies.
    Wagner KR; Hua Y; de Courten-Myers GM; Broderick JP; Nishimura RN; Lu SY; Dwyer BE
    Cell Mol Biol (Noisy-le-grand); 2000 May; 46(3):597-608. PubMed ID: 10872746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An early (sixth-hour) serum bilirubin measurement is useful in predicting the development of significant hyperbilirubinemia and severe ABO hemolytic disease in a selective high-risk population of newborns with ABO incompatibility.
    Sarici SU; Yurdakök M; Serdar MA; Oran O; Erdem G; Tekinalp G; Yiğit S
    Pediatrics; 2002 Apr; 109(4):e53. PubMed ID: 11927726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is breastfeeding really favoring early neonatal jaundice?
    Bertini G; Dani C; Tronchin M; Rubaltelli FF
    Pediatrics; 2001 Mar; 107(3):E41. PubMed ID: 11230622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased response to phototherapy for neonatal jaundice in breast-fed infants.
    Tan KL
    Arch Pediatr Adolesc Med; 1998 Dec; 152(12):1187-90. PubMed ID: 9856427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stannsoporfin with phototherapy to treat hyperbilirubinemia in newborn hemolytic disease.
    Rosenfeld WN; Hudak ML; Ruiz N; Gautam S;
    J Perinatol; 2022 Jan; 42(1):110-115. PubMed ID: 34635771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A multicenter randomized controlled study on the efficacy and safety of Yinzhihuang oral solution for the treatment of neonatal indirect hyperbilirubinemia in term newborn infants].
    Clinical Research Collaborative Group of Yinzhihuang Oral Solution
    Zhonghua Er Ke Za Zhi; 2011 Sep; 49(9):663-8. PubMed ID: 22176900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.